The table below shows Xenon Pharmaceuticals Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$88.51M
$77.05M
$74.98M
$61.20M
$56.97M
$49.70M
SG&A
XENE annual revenue (10-K history)
Xenon Pharmaceuticals Inc. reported annual revenue of $311.00K for fiscal year 2017. That is down 82.8% from $1.80M in fiscal 2016. Over the 6 fiscal years shown, annual revenue declined from $14.31M (FY 2012) to $311.00K. Figures come from the company's audited annual reports as filed with the SEC.